Pulmonary Hypertension Research and Diagnosis Act of 2013

Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA H.R. 2073 & S 1453: Pulmonary Hypertension Research & Diagnosis Act H.R. 460: Patients' Access to Treatments Act H.R. 3114: MODDERN Cures Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)

H.R. 1701, Cutting Costly Codes Act of 2013, all provisions S. 972, Cutting Costly Codes Act of 2013, all provisions H.R. 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013, all provisions H.R. 2835, Restoring Access to Medication Act of 2013, all provisionsS. 1323, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013, all provisions H.R. 3204, Drug Quality and Security Act, provisions relating to drug compounding S. 959, Pharmaceutical Quality, Security, and Accountability Act, all provisions H.R. 3089, Compounding Clarity Act of 2013, all provisions H.R. 2094, School Access to Emergency Epinephrine Act, all provisions H.R. 2073, Pulmonary Hypertension Research and Diagnosis Act of 2013, all provisions Affordable Care Act - repeal of Section 9003 - HSA/FSA OTC drugs prescription requirement Affordable Care Act Section 2607(a) - Provider Non-discrimination Genetic Information Nondiscrimination Act Personalized Medicine Electronic Health Records - Meaningful Use Regulations Health Information Technology In-office Ancillary Services Exception Prescription Drug Diversion and Abuse Regulation of laboratory developed tests Prescriber education and mandatory/voluntary CME training Pay-for-delay Physician Coding Rogue Online/Internet Pharmacies Telehealth/Telemedicine Prescription Drug Compounding Drug Shortages ICD-10 Repeal HIPAA Privacy/Security issues and accounting for disclosures Physician Compare Redesign Opioid Analgesics Shared Savings/Accountable Care Organization program Delivery Reform Health Insurance Reform Marketing of high stimulant/caffeine drinks to children Sunshine Act Supplemental Nutrition Assistance Program (SNAP)

Client expense: $4,270,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, White House Office